Category Archives: leadership

Forbes Health Summit: Industry Leaders Ponder the New World of Consumer-Driven Care

In health care, it is the lowly consumer who is now calling the shots, driving product and process innovation in areas ranging from electronic medical records [EMR] to retail health clinics. This was the main theme among discussants at the Forbes magazine Healthcare Summit held here in New York on October 10.  The central question:  […]
Also posted in Meetings, patient education, R&D, Strategy | Tagged , , , , , , , , , , , | Leave a comment

National Chains Carefully Circle Obamacare

by Tom Norton While US Pharma anxiously watches the initial roll out of Obamacare, there are those entities closely associated with the innovator Rx business that have a very different view on what Obamacare means to their concerns.  These firms are carefully circling the new law, thoughtfully observing its implementation, and, generally, viewing its startup […]
Also posted in Guest Blog, healthcare, Legal, Market Access, Regulatory | Tagged , , , , , , , , , , | Leave a comment

How to Win in the Diabetes Space

Novo Nordisk’s SVP of national diabetes sales speaks with PharmExec about a new field force technology initiative, implications of the Sunshine Act, and why Victoza sales won’t slow down anytime soon. At a time when meaningful growth at most big pharma companies is happening in emerging markets – and nowhere else – Novo’s 2Q earnings […]
Also posted in compliance, FDA, healthcare, patient education, People, Sales, Strategy, Technology | Tagged , , , , , , , , , | 5 Comments

Tackling the Skills Shortfall in Revenue Management and Profit Optimization

By Alex Rumble. As the life sciences industry looks to manage top and bottom line performance more effectively, there is a common concern among providers about the lack of in-house talent and expertise. End-to-end revenue lifecycle management has emerged as a powerful methodology that places price and profit maximization firmly on the boardroom agenda. But as a […]
Also posted in Guest Blog, Op-Ed, People | Tagged , , , , | 1 Comment

CEO Interview: Harvey Berger, Ariad Pharmaceuticals

Eight months into the launch of its first approved drug – Iclusig (ponatinib), a small molecule therapy indicated for two rare forms of leukemia – Ariad Pharmaceuticals’ principal founder and CEO Harvey Berger says doing it all, from discovery to global commercialization, is the company’s path to sustainability and the way to take on Big […]
Also posted in Biotech, Europe, Gene therapy, Global, Market Access, Marketing, pricing, R&D, Regulatory, Safety, Sales, Strategy, Technology | Tagged , , , , , , , , , | Leave a comment
  • Categories

  • Meta